Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) traded up 47.4% on Friday . The company traded as high as C$0.14 and last traded at C$0.14. 1,312,210 shares changed hands during mid-day trading, an increase of 427% from the average session volume of 249,010 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Stock Performance
The stock has a market capitalization of C$19.53 million, a price-to-earnings ratio of -14.00 and a beta of 0.32. The company has a 50 day simple moving average of C$0.08 and a 200-day simple moving average of C$0.06. The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Featured Stories
- Five stocks we like better than Voyageur Pharmaceuticals
- Health Care Stocks Explained: Why You Might Want to Invest
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- Stock Market Upgrades: What Are They?
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- What Are Dividend Champions? How to Invest in the Champions
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
